ClinicalTrials.Veeva

Menu

Effect of a Cooling Sensation Flavor on the Swallow Response in Post-stroke Patients With Oropharyngeal Dysphagia

H

Hospital de Mataró

Status

Enrolling

Conditions

Stroke
Oropharyngeal Dysphagia
Swallowing Disorder

Treatments

Dietary Supplement: Pre-thickened oral nutritional supplement without a cooling sensation flavour
Dietary Supplement: Pre-thickened oral nutritional supplement with a cooling sensation flavour

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06250426
Refresh

Details and patient eligibility

About

Current oropharyngeal dysphagia (OD) treatment in older patients is based on compensatory strategies (fluid thickening and texture modified diets) that improve swallow safety but do not improve the swallowing function. One of these strategies is thickening products, which are used to reduce pharyngeal bolus velocity by increasing viscosity of fluids. There are several studies demonstrating the therapeutic effect of thickeners in reducing the prevalence of penetrations and aspirations, and their use has been correlated with reduced prevalence of respiratory infections, aspiration pneumonia and hospital readmissions.

In recent years, new neurorehabilitation treatment strategies for OD have been developed such as peripheral (electrical or chemical stimulation) or central stimulation (transcranial direct current stimulation or repetitive transcranial magnetic stimulation).

The investigators suggest that new generation treatments for OD have to combine thickened fluids and about peripheral stimulation using transient receptor potential (TRP) channels agonists. The aim of this study is to evaluate the therapeutic effect of a cooling sensation (CS) flavor in a pre-thickened oral nutritional supplement (ONS) drink on the biomechanical mechanism of the swallow response in chronic post-stroke patients with OD.

The investigators designed a randomized, crossover, interventional and open-label clinical study. The study includes 2 groups: 1) n=25: 1st visit: stimulation with Control, 2nd visit: stimulation with CS; and 2) n=25: 1st visit: stimulation with CS, 2nd visit: stimulation with Control. Each patient will attend a total of 2 visits, with a washing period of at least 7 days between visits. The procedures to be performed during each visit are: clinical assessment of swallowing with V-VST, spontaneous swallowing frequency measurement using electromyography, and collection of a sample of saliva using a Salivette®.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years
  • Patients with chronic OD as a consequence of stroke (more than 3 month since stroke diagnostic)
  • Patients with impaired safety and/or efficacy of swallow (V-VST)
  • Patients that can swallow safely the investigation and control product according to the viscosity of the product and the results of the V-VST
  • Patients able to follow the protocol and give informed consent

Exclusion criteria

  • Pregnancy
  • Life expectancy <3 months or palliative care
  • OD diagnosis prior to stroke
  • Dementia (GDS 4 or higher)
  • Allergy to the investigation and/or control product or to any of its components
  • Participation in another interventional study in the month prior to inclusion
  • Current users of a pre-thickened ONS drink with cooling sensation flavor

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

50 participants in 2 patient groups, including a placebo group

Active
Active Comparator group
Description:
Pre-thickened oral nutritional supplement with a cooling sensation flavour
Treatment:
Dietary Supplement: Pre-thickened oral nutritional supplement with a cooling sensation flavour
Control
Placebo Comparator group
Description:
Pre-thickened oral nutritional supplement without a cooling sensation flavour
Treatment:
Dietary Supplement: Pre-thickened oral nutritional supplement without a cooling sensation flavour

Trial contacts and locations

1

Loading...

Central trial contact

Pere Clavé, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems